224 related articles for article (PubMed ID: 22653896)
1. Photodynamic therapy in melanoma--an update.
Baldea I; Filip AG
J Physiol Pharmacol; 2012 Apr; 63(2):109-18. PubMed ID: 22653896
[TBL] [Abstract][Full Text] [Related]
2. Melanogenesis and DNA damage following photodynamic therapy in melanoma with two meso-substituted porphyrins.
Baldea I; Olteanu DE; Bolfa P; Tabaran F; Ion RM; Filip GA
J Photochem Photobiol B; 2016 Aug; 161():402-10. PubMed ID: 27314538
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic Therapy in Melanoma - Where do we Stand?
Baldea I; Giurgiu L; Teacoe ID; Olteanu DE; Olteanu FC; Clichici S; Filip GA
Curr Med Chem; 2018; 25(40):5540-5563. PubMed ID: 29278205
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
5. Direct tumor damage mechanisms of photodynamic therapy.
Nowis D; Makowski M; Stokłosa T; Legat M; Issat T; Gołab J
Acta Biochim Pol; 2005; 52(2):339-52. PubMed ID: 15990919
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
7. The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy.
Krzykawska-Serda M; Dąbrowski JM; Arnaut LG; Szczygieł M; Urbańska K; Stochel G; Elas M
Free Radic Biol Med; 2014 Aug; 73():239-51. PubMed ID: 24835769
[TBL] [Abstract][Full Text] [Related]
8. Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy.
Davids LM; Kleemann B; Cooper S; Kidson SH
Cell Biol Int; 2009 Oct; 33(10):1065-72. PubMed ID: 19596456
[TBL] [Abstract][Full Text] [Related]
9. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy--indications and limits in malignant tumors treatment.
Filip AG; Clichici S; Daicoviciu D; Olteanu D; Mureşan A; Dreve S
Rom J Intern Med; 2008; 46(4):285-93. PubMed ID: 19480294
[TBL] [Abstract][Full Text] [Related]
11. Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene.
Otake E; Sakuma S; Torii K; Maeda A; Ohi H; Yano S; Morita A
Photochem Photobiol; 2010; 86(6):1356-63. PubMed ID: 20796243
[TBL] [Abstract][Full Text] [Related]
12. Morphologic effects of bacteriochlorin a and light in vivo on intraocular melanoma.
Schuitmaker JJ; Vrensen GF; van Delft JL; de Wolff-Rouendaal D; Dubbelman TM; de Wolf A
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2683-8. PubMed ID: 1894468
[TBL] [Abstract][Full Text] [Related]
13. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines.
Kolarova H; Tomankova K; Bajgar R; Kolar P; Kubinek R
Ultrasound Med Biol; 2009 Aug; 35(8):1397-404. PubMed ID: 19515482
[TBL] [Abstract][Full Text] [Related]
15. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
16. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy in treatment of cutaneous and choroidal melanoma.
Kawczyk-Krupka A; Bugaj AM; Latos W; Zaremba K; Sieroń A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):503-9. PubMed ID: 24284103
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
19. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death.
Sharma KV; Davids LM
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):156-63. PubMed ID: 22594986
[TBL] [Abstract][Full Text] [Related]
20. Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32) - in vitro studies.
Szlasa W; Supplitt S; Drąg-Zalesińska M; Przystupski D; Kotowski K; Szewczyk A; Kasperkiewicz P; Saczko J; Kulbacka J
Biomed Pharmacother; 2020 Dec; 132():110883. PubMed ID: 33113417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
